David Goldberg, United States
HCV Cure Rates in the THINKER-NEXT Trial of Transplanting Kidneys from HCV-Infected Donors into HCV-Negative Recipients

Victoria Hall, Canada
Adjuvanted Respiratory Syncytial Virus (RSV) Vaccination in High-risk Transplant Recipients

Nadiesda Costa, United States
Potravitug for the Treatment of BK Polyomavirus Infection in Kidney Transplant Recipients: a Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Hans Hirsch, Switzerland
Developing CD8 T cell mRNA Vaccines Targeting BK Polyomavirus Large T Antigen

Anne Dipchand, Canada
Early experience with MMR vaccination in pediatric heart transplant recipients

Rakesh Sindhi, United States
Cytomegalovirus-specific CD40LG-expressing T-cells are present before transplantation in CMV-seronegative recipients and predict early CMV DNAemia.

Maria Margarita Anders, Argentina
Liver and Kidney Transplantation with Organs from Chagas Disease Positive Donors: A Valuable Resource That Requires Close Monitoring

Ian McGowan, Denmark
Ex Vivo Targeting of the Latent Cytomegalovirus Reservoir in Human Kidneys to Prevent Virus Reactivation Post Transplantation